302 related articles for article (PubMed ID: 19109580)
1. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Torbey MT; Jauch E; Liebeskind DS;
N Engl J Med; 2008 Dec; 359(26):2839; author reply 2841. PubMed ID: 19109580
[No Abstract] [Full Text] [Related]
2. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Morris DC
N Engl J Med; 2008 Dec; 359(26):2841; author reply 2841. PubMed ID: 19115492
[No Abstract] [Full Text] [Related]
3. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Schwamm LH; Fonarow GC
N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115490
[No Abstract] [Full Text] [Related]
4. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Fitzpatrick AE; Noone I; O'Shea DD
N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115491
[No Abstract] [Full Text] [Related]
5. [Treatment of acute ischemic apoplexy].
Andersen G; Krieger DW; Iversen HK
Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
[No Abstract] [Full Text] [Related]
6. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
[TBL] [Abstract][Full Text] [Related]
7. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
8. [Can the target group for thrombolysis in acute ischemic stroke be widened? Current indication is very narrow--new study results are necessary].
Murray V
Lakartidningen; 2011 Jan 12-18; 108(1-2):16-7. PubMed ID: 21365808
[No Abstract] [Full Text] [Related]
9. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis.
Strbian D; Sairanen T; Rantanen K; Piironen K; Atula S; Tatlisumak T; Soinne L;
Cerebrovasc Dis; 2011; 31(1):37-42. PubMed ID: 20980752
[TBL] [Abstract][Full Text] [Related]
10. Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke.
Shah SH; Liebeskind DS; Saver JL; Starkman S; Vinuela F; Duckwiler G; Jahan R; Kim D; Sanossian N; Vespa P; Ovbiagele B
Neurology; 2006 Jun; 66(11):1745-6. PubMed ID: 16769954
[TBL] [Abstract][Full Text] [Related]
11. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?
Parsons MW
Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346
[No Abstract] [Full Text] [Related]
12. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
Jahan R; Vinuela F
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
[TBL] [Abstract][Full Text] [Related]
13. [Thrombolytic therapy in acute ischemic stroke. Critical analysis of current knowledge].
Murray V; Norrving B; Terént A; Wester P
Lakartidningen; 2004 Feb; 101(8):662-8, 670-3. PubMed ID: 15024939
[TBL] [Abstract][Full Text] [Related]
14. Current acute stroke trials and their potential impact on the therapeutic time window.
Schellinger PD; Köhrmann M
Expert Rev Neurother; 2012 Feb; 12(2):169-77. PubMed ID: 22288672
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.
Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB
Cerebrovasc Dis; 2010; 29(1):79-81. PubMed ID: 19907167
[TBL] [Abstract][Full Text] [Related]
16. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban.
van Hooff RJ; Nieboer K; De Smedt A; Yperzeele L; Jochmans K; De Keyser J; Brouns R
Clin Neurol Neurosurg; 2014 Jul; 122():133-4. PubMed ID: 24813326
[No Abstract] [Full Text] [Related]
17. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
Uchino K; Massaro L; Hammer MD
Cerebrovasc Dis; 2010; 29(1):57-61. PubMed ID: 19893313
[TBL] [Abstract][Full Text] [Related]
18. Comment on "Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008".
Sharma VK; Teoh HL; Chan BP
J Clin Neurosci; 2010 Apr; 17(4):543-4. PubMed ID: 20167497
[No Abstract] [Full Text] [Related]
19. Thrombolysis in acute ischemic stroke.
Lang W; Domanovits H; Görzer H; Germann P; Gatterbauer E; Segall B
Acta Anaesthesiol Scand Suppl; 1997; 111():34-7. PubMed ID: 9420947
[No Abstract] [Full Text] [Related]
20. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]